0:00 What if you could edit the very code of life, not with a billion-dollar lab, but with the precision of a word processor's find-and-replace function?0:11 It sounds like science fiction.0:14 But it’s happening right now.0:16 It is.0:16 And much like our story last week on the battle for insulin, this isn't a story of calm, quiet discovery.0:24 This is a story of obsession, of bitter rivalry, and a moment that changed everything.0:31 This is the story of CRISPR.0:33 It starts in a place most people wouldn't look.0:37 Not in a fancy university lab, but in the salt marshes of Spain, with a scientist named Francisco Mojica.0:45 He was studying microbes.0:47 And he kept seeing...0:49 something strange in their DNA.0:51 Strange how?0:52 He saw these repeating patterns.0:55 Palindromes.0:56 Spaced out in a very regular way.0:58 For years, nobody knew what they were.1:01 They were just a curiosity.1:03 But Mojica was obsessed.1:05 He called them CRISPRs.1:07 And what he’d stumbled upon wasn't just a quirk of biology.1:12 It was an ancient weapon.1:14 Exactly.1:14 It was a bacterial immune system.1:17 A library of mugshots, you could say.1:20 When a virus attacked, the bacteria would grab a snippet of the virus's DNA and store it in its own genetic code, right there in those CRISPR sequences.1:32 So if that same virus ever showed up again...1:35 The bacteria would recognize it, and an enzyme—a little molecular scissor—would go out, find the matching viral DNA, and just...1:45 snip it to pieces.1:47 End of invasion.1:48 So for years, this is just a fascinating quirk of microbiology.1:53 But then, two scientists, Emmanuelle Charpentier and Jennifer Doudna, have a thought.1:59 A thought that changes the world.2:02 They realized, what if we could control this?2:05 What if we could give that molecular scissor, the Cas9 enzyme, our OWN instructions?2:12 Not a snippet of virus DNA, but the sequence for, say, a faulty gene that causes a disease.2:19 Wait—so you're saying they figured out how to hijack a bacterial defense system and turn it into a programmable editing tool?2:29 That's the 2012 breakthrough.2:31 That is the eureka moment.2:33 They showed you could program this system to cut ANY DNA sequence, anywhere you wanted.2:40 The implications were...2:42 staggering.2:43 And immediately, the race was on.2:45 Because it's one thing to do this in a test tube.2:49 It's another thing entirely to make it work in a human cell.2:54 Right.2:54 And this is where the rivalry really ignites.2:58 While Doudna and Charpentier had published the foundational work, a team at the Broad Institute, led by Feng Zhang, published a paper just months later showing they had successfully used CRISPR to edit genes in mammalian cells.3:16 Human cells.3:17 And that led to one of the most brutal patent battles in modern science.3:22 Who really "invented" CRISPR as a tool for human medicine?3:27 The team that discovered the mechanism, or the team that first showed it working where it mattered most?3:35 It's a conflict that, in some ways, is still being fought.3:39 But while the lawyers were fighting, the science was just exploding.3:45 Because now, the tool was in thousands of hands.3:48 And the first target was obvious: genetic diseases.3:52 Horrible conditions caused by a single typo in a person's DNA.3:57 Like sickle cell disease.3:59 A single letter is wrong in the genetic code, and it twists red blood cells into a crescent shape, causing excruciating pain and organ damage.4:10 For decades, all medicine could do was manage the symptoms.4:15 But with CRISPR...4:16 you could, in theory, go in and correct the typo.4:20 Permanently.4:21 And in 2023, the theory became reality.4:24 The FDA approved a therapy called Casgevy.4:27 The first-ever approved CRISPR-based medicine.4:31 I remember reading a quote from a scientist, Fyodor Urnov, around that time.4:37 He said, "At this point, all hypotheticals...4:41 are gone.4:41 CRISPR is curative.4:43 Two diseases down, 5,000 to go." Wow.4:46 That sends a shiver down your spine.4:48 Two down, five thousand to go.4:51 It’s the end of the beginning.4:53 The proof of principle.4:55 But the story doesn't stop there, does it?4:58 Because that first version of CRISPR, as revolutionary as it was, had...5:04 issues.5:04 It did.5:05 The Cas9 enzyme is, um, physically quite large, which makes it hard to deliver into the body.5:12 And there were always concerns about "off-target effects"—the scissors cutting in the wrong place.5:20 It's like trying to perform surgery with a chainsaw when you really need a scalpel.5:26 A bit.5:27 But the innovation just keeps accelerating.5:30 Earlier this year, a team announced a new, much smaller CRISPR enzyme that's over eighty percent efficient, compared to less than ten percent for some older versions.5:43 Which means you can potentially pack it into a harmless virus and inject it directly into a patient.5:51 No more taking cells out, editing them, and putting them back in.5:56 It opens the door to treating things like cancer or ALS inside the body.6:02 And another group in Australia developed a method that doesn't even cut the DNA.6:08 It just...6:09 switches good genes back on.6:11 Professor Merlin Crossley described it as getting the training wheels back on a bike for people who need new wheels.6:20 So we’re moving from find-and-replace to just...6:24 turning up the volume on a gene that's been silenced.6:28 It’s a safer, more subtle approach.6:31 And it shows how this story is constantly evolving.6:35 The discovery, the rivalry...6:37 it was all just the first chapter.6:40 The real story is just getting started.6:43 It's a reminder that this is general information, of course, not medical advice, but the pace of change is just breathtaking.6:52 From a Spanish salt marsh to a cure for a disease that has tormented humanity for centuries.7:00 All in the span of a few decades.7:02 It’s the greatest story you’ve never read.
